A Targeted Therapy Next in Line for Biomarker-based Cancer Drug Approval?
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
Category: Featured
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
Today is National “Don’t Fry Day,” an initiative undertaken by the National Council on Skin Cancer Prevention to encourage...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association...
The American Association for Cancer Research (AACR) Annual Meeting 2017 brought some of the world’s greatest scientific minds to...
On March 23, the U.S. Food and Drug Administration announced the first-ever approval of a treatment for patients with...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
At the 2017 Annual Meeting, the AACR is expanding its social media profile to include Snapchat and Instagram.